AIM Vaccine Co., Ltd. (6660.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for AIM Vaccine Co., Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -5.24x |
| P/B Ratio | 1.28x |
| P/S Ratio | 3.03x |
| Profitability | |
| Gross Margin | 65.2% |
| Operating Margin | -17.4% |
| Net Margin | -57.9% |
| EBITDA Margin | -7.7% |
| Liquidity | |
| Current Ratio | 0.66x |
| Quick Ratio | 0.55x |
| Leverage | |
| Debt/Equity | 0.64x |
YoY = year-over-year change. Source: FMP..